Related Experiment Video
Updated: Aug 8, 2026
07:14
Phenotypic Characterization of Macrophages from Rat Kidney by Flow Cytometry
Published on: October 18, 2016
Macrophage accumulation in human progressive diabetic nephropathy
1Department of Nephrology, Monash Medical Centre, Clayton, Australia.
Nephrology (Carlton, Vic.)
|June 8, 2006
Summary
Macrophages accumulate in the kidneys of patients with diabetic nephropathy. Higher interstitial macrophage levels correlate with faster decline in renal function, supporting their pathogenic role.
Area of Science:
- Nephrology
- Immunology
- Pathology
Background:
- Diabetic nephropathy is a leading cause of kidney failure globally.
- Mechanisms driving disease progression remain unclear.
- Macrophage involvement is suggested by experimental models.
Purpose of the Study:
- To investigate macrophage accumulation in diabetic nephropathy.
- To determine the relationship between macrophage infiltration and disease progression.
Main Methods:
- Retrospective analysis of 20 diabetic nephropathy patients.
- Quantified interstitial and glomerular macrophages (KP-1/anti-CD68+ cells).
- Correlated macrophage levels with baseline proteinuria, tubulointerstitial damage, and 5-year renal function decline.
Main Results:
- Increased macrophages in glomeruli and interstitium in diabetic nephropathy patients compared to controls.
- Interstitial macrophage accumulation strongly correlated with serum creatinine, proteinuria, and fibrosis.
- Interstitial macrophage levels inversely correlated with the rate of renal function decline.
Conclusions:
- Macrophages infiltrate both glomeruli and interstitium in diabetic nephropathy.
- Interstitial macrophage density predicts the rate of kidney function decline.
- Findings support a pathogenic role for macrophages in diabetic nephropathy progression.
Related Concept Videos
01:28Diabetic Nephropathy
Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
01:27Diabetic Retinopathy
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:38Inflammation
Overview